Integrated Filing — IndAS



General information about company

Scrip Code 532488
NSE Symbol DIVISLAB
MSEI Symbol NOTLISTED
ISIN INE361B01024
Name of company Divi's Laboratories Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 23-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 14-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacture of Active Pharmaceutical Ingredients, Intermediates and Nutraceutical Ingredients
Start date and time of board meeting 23-05-2026   10:15:00
End date and time of board meeting 23-05-2026   11:50:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 2,83,100.00 10,56,000.00
Other income 15,500.00 50,700.00
Total income 2,98,600.00 11,06,700.00
2 Expenses
(a) Cost of materials consumed 1,21,400.00 4,37,800.00
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (9,500.00) (28,500.00)
(d) Employee benefit expense 38,100.00 1,44,200.00
(e) Finance costs 600.00 2,300.00
(f) Depreciation, depletion and amortisation expense 12,000.00 46,300.00
(f) Other Expenses
1 Other Expenses 39,700.00 1,58,400.00
Total other expenses 39,700.00 1,58,400.00
Total expenses 2,02,300.00 7,60,500.00
3 Total profit before exceptional items and tax 96,300.00 3,46,200.00
4 Exceptional items 0.00 (7,400.00)
5 Total profit before tax 96,300.00 3,38,800.00
6 Tax expense
7 Current tax 24,900.00 86,800.00
8 Deferred tax (3,700.00) (4,800.00)
9 Total tax expenses 21,200.00 82,000.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 75,100.00 2,56,800.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 75,100.00 2,56,800.00
17 Other comprehensive income net of taxes (100.00) 2,100.00
18 Total Comprehensive Income for the period 75,000.00 2,58,900.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 75,100.00 2,56,800.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 75,000.00 2,58,900.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 5,300.00 5,300.00
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 16,70,800.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 28.31 96.75
Diluted earnings (loss) per share from continuing operations 28.31 96.75
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 28.31 96.75
Diluted earnings (loss) per share from continuing and discontinued operations 28.31 96.75
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The above Statement of consolidated audited financial results for the quarter and year ended March 31, 2026, Consolidated audited statement of assets and liabilities and Consolidated audited statement of cash flows as at and for the year ended March 31, 2026 (Consolidated statements) are prepared in accordance with the recognition and measurement principles laid down in applicable Indian Accounting Standards (lndAS) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended. The Consolidated statements have been reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on May 23, 2026. The statutory auditors have audited the consolidated statements and issued an unmodified report thereon. 2. The consolidated financial results include the audited financial results of the wholly owned subsidiaries viz., Divis Laboratories (USA) Inc and Divi’s Laboratories Europe AG. 3. The Group is engaged in the manufacture of Active Pharmaceutical Ingredients, intermediates and nutraceutical ingredients; and the same constitutes a single reportable business segment as per Ind AS 108. 4. The Group does not have any discontinued operations and the Profit for the year represents the Profits from continuing operations only. 5. On November 21, 2025, the Government of India notified the four labour codes viz., the Code on Wages, 2019, the Industrial Relations Code, 2020, the Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, (Labour Codes) consolidating twenty nine existing labour laws. The Ministry of Labour and Employment notified central rules and issued FAQs to enable assessment of the financial impact due to changes in regulations. The Parent Company has assessed the impact based on the best available information and recognised the incremental impact of employee benefits expense of Rs.74 crores. The said incremental impact primarily arises due to change in the definition of wages and the same has been accounted in accordance with the applicable accounting standards. Considering its non-recurring nature and amount involved, such incremental impact is presented under Exceptional items in the Consolidated statements. The Parent Company continues to monitor the developments pertaining to implementation of Labour Codes and will provide the appropriate impact in accordance with applicable accounting standards, if any. 6. Financial results for the quarter ended March 31, 2026 and corresponding quarter ended March 31, 2025 are the balancing figures between audited figures in respect of the full financial year and the unaudited published year-to-date figures up to the third quarter of the respective financial years, which were subject to limited review. 7. The Board of Directors of the company has recommended a dividend of Rs. 30 per share of face value Rs.2 each i.e.1500 percentage for the financial year 2025 26, subject to approval of members at the ensuing annual general meeting. 8. Forex gain included in Other Income for the respective periods is as given below. (Rs. in Crores) Quarter ended Year Ended 31.03.2026 31.12.2025 31.03.2025 31.03.2026 31.03.2025 (Audited) (Unaudited) (Audited) (Audited) (Audited) Forex gain 90 19 10 211 48



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 6,51,500.00
Capital work-in-progress 2,11,300.00
Investment property
Goodwill 0.00
Other intangible assets 1,300.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 6,900.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 6,700.00
Total of other non-current financial assets 6,700.00
Total non-current financial assets 13,600.00
Deferred tax assets (net) 1,400.00
Other non-current assets
1 Other non-current assets 14,600.00
Total of other non-current assets 14,600.00
Total non-current assets 8,93,700.00
2 Current assets
Inventories 3,95,400.00
Current financial asset
Current investments 0.00
Trade receivables, current 2,98,400.00
Cash and cash equivalents 12,800.00
Bank balance other than cash and cash equivalents 3,28,600.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 800.00
Total current financial assets 6,40,600.00
Current tax assets (net)
Other current assets
1 Other current assets 73,600.00
Total of other current assets 73,600.00
Total current assets 11,09,600.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 20,03,300.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 5,300.00
Other equity 16,70,800.00
Total equity attributable to owners of parent 16,76,100.00
Non controlling interest
Total equity 16,76,100.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises
Total Trade payable
Other non-current financial liabilities
1 Other non-current financial liabilities 46,100.00
Total of other non-current financial liabilities 46,100.00
Total non-current financial liabilities 46,100.00
Provisions, non-current 8,100.00
Deferred tax liabilities (net) 46,900.00
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 21,800.00
Total of other non-current liabilities 21,800.00
Total non-current liabilities 1,22,900.00
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 6,200.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 1,14,900.00
Total Trade payable 1,21,100.00
Other current financial liabilities
1 Other current financial liabilities 46,200.00
Total of other current financial liabilities 46,200.00
Total current financial liabilities 1,67,300.00
Other current liabilities 29,800.00
1 Other current liabilities 29,800.00
Total of other current liabilities 29,800.00
Provisions, current 6,000.00
Current tax liabilities (Net) 1,200.00
Deferred government grants, Current
Total current liabilities 2,04,300.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 3,27,200.00
Total equity and liabilites 20,03,300.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Gain/loss on Remeasurement of post-employment benefit obligations (800.00) 800.00
Total Amount of items that will not be reclassified to profit and loss (800.00) 800.00
2 Income tax relating to items that will not be reclassified to profit or loss (200.00) 200.00
3 Amount of items that will be reclassified to profit and loss
1 Gain/(loss) on exchange differences in translating the financial statements of foreign operations 700.00 2,000.00
Total Amount of items that will be reclassified to profit and loss 700.00 2,000.00
4 Income tax relating to items that will be reclassified to profit or loss 200.00 500.00
5 Total Other comprehensive income (100.00) 2,100.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 3,38,800.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,300.00
Adjustments for decrease (increase) in inventories (71,800.00)
Adjustments for decrease (increase) in trade receivables, current (14,100.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets (35,000.00)
Adjustments for other financial assets, non-current 200.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 29,400.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 43,900.00
Adjustments for depreciation and amortisation expense 46,300.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 100.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 57,300.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains (8,600.00)
Adjustments for dividend income 0.00
Adjustments for interest income 28,400.00
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) (400.00)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 0.00
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 21,200.00
Net cash flows from (used in) operations 3,60,000.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 86,200.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 2,73,800.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 300.00
Purchase of property, plant and equipment 2,52,000.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 28,400.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 1,400.00
Net cash flows from (used in) investing activities (2,21,900.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 0.00
Payments of lease liabilities 200.00
Dividends paid 79,700.00
Interest paid 500.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (80,400.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (28,500.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (28,500.00)
Cash and cash equivalents cash flow statement at beginning of period 41,300.00
Cash and cash equivalents cash flow statement at end of period 12,800.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 Price Waterhouse Chartered Accountants LLP Yes 30-11-2026